Gallagher S - Search Results

1

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Emran AA, Tseng HY, Coleman MC, Tiffen J, Cook S, McGuire HM, Gallagher S, Feng C, Hersey P. Emran AA, et al. Among authors: gallagher s. Pigment Cell Melanoma Res. 2020 Sep;33(5):660-670. doi: 10.1111/pcmr.12870. Epub 2020 Feb 20. Pigment Cell Melanoma Res. 2020. PMID: 32027447 Free PMC article. Review.

2

EZH2: an emerging role in melanoma biology and strategies for targeted therapy.

Tiffen J, Gallagher SJ, Hersey P. Tiffen J, et al. Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27. Pigment Cell Melanoma Res. 2015. PMID: 24912396 Review.

3

EZH2 as a mediator of treatment resistance in melanoma.

Tiffen JC, Gallagher SJ, Tseng HY, Filipp FV, Fazekas de St. Groth B, Hersey P. Tiffen JC, et al. Pigment Cell Melanoma Res. 2016 Sep;29(5):500-7. doi: 10.1111/pcmr.12481. Epub 2016 May 25. Pigment Cell Melanoma Res. 2016. PMID: 27063195 Free PMC article. Review.

4

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma.

Ahmed F, Tseng HY, Ahn A, Gunatilake D, Alavi S, Eccles M, Rizos H, Gallagher SJ, Tiffen JC, Hersey P, Emran AA. Ahmed F, et al. Among authors: gallagher sj. J Invest Dermatol. 2022 May;142(5):1444-1455.e10. doi: 10.1016/j.jid.2021.09.030. Epub 2021 Oct 22. J Invest Dermatol. 2022. PMID: 34695412 Free article.

5

A focus on PD-L1 in human melanoma.

Hersey P, Gallagher S. Hersey P, et al. Among authors: gallagher s. Clin Cancer Res. 2013 Feb 1;19(3):514-6. doi: 10.1158/1078-0432.CCR-12-3312. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251000

6

Intralesional immunotherapy for melanoma.

Hersey P, Gallagher S. Hersey P, et al. Among authors: gallagher s. J Surg Oncol. 2014 Mar;109(4):320-6. doi: 10.1002/jso.23494. Epub 2013 Dec 3. J Surg Oncol. 2014. PMID: 24301265 Review.

7

Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.

Gallagher SJ, Mijatov B, Gunatilake D, Gowrishankar K, Tiffen J, James W, Jin L, Pupo G, Cullinane C, McArthur GA, Tummino PJ, Rizos H, Hersey P. Gallagher SJ, et al. Pigment Cell Melanoma Res. 2014 Nov;27(6):1126-37. doi: 10.1111/pcmr.12282. Epub 2014 Jul 3. Pigment Cell Melanoma Res. 2014. PMID: 24924589

8

Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.

Gowrishankar K, Gunatilake D, Gallagher SJ, Tiffen J, Rizos H, Hersey P. Gowrishankar K, et al. PLoS One. 2015 Apr 6;10(4):e0123410. doi: 10.1371/journal.pone.0123410. eCollection 2015. PLoS One. 2015. PMID: 25844720 Free PMC article.

9

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Gallagher SJ, Tiffen JC, Hersey P. Gallagher SJ, et al. Cancers (Basel). 2015 Sep 25;7(4):1959-82. doi: 10.3390/cancers7040870. Cancers (Basel). 2015. PMID: 26426052 Free PMC article. Review.

10

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.

Tiffen J, Wilson S, Gallagher SJ, Hersey P, Filipp FV. Tiffen J, et al. Among authors: gallagher sj. Neoplasia. 2016 Feb;18(2):121-32. doi: 10.1016/j.neo.2016.01.003. Neoplasia. 2016. PMID: 26936398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,008 results

Search Page